Most of the evidence points to a pro-hypertrophy, proinflammatory and pro-fibrotic effect of p38 activation on the onset of HF and arrhythmias, which involves cardiac fibrosis, alterations to Ca2+-handling proteins, and the modulation of gap junctions in cardiomyocytes [3, 35]. Here, MAPK14 is linked to cardiac arrhythmia.